§ 13F · FUND PROFILE
Atle Fund Management AB.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $27.0T (13F)Positions · 38Turnover · — · Q4Filed · Feb 6, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$39.1T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 6, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 31K | $33.5T | 10.7% | −16% |
| 2 | ABBV | AbbVie Inc | 108K | $24.7T | 7.9% | +17% |
| 3 | MRK | Merck & Co. Inc | 196K | $20.6T | 6.6% | +22% |
| 4 | TMO | Thermo Fisher Scientific Corp | 30K | $17.3T | 5.5% | +10% |
| 5 | NBIX | Neurocrine Biosciences Inc | 95K | $13.4T | 4.3% | −8% |
| 6 | ISRG | Intuitive Surgical Inc | 22K | $12.6T | 4.0% | +13% |
| 7 | ONC | BEONE MEDICINES LTD-ADR | 40K | $12.3T | 3.9% | +33% |
| 8 | BBIO | Bridgebio Pharma Inc | 141K | $10.8T | 3.4% | −19% |
| 9 | VRTX | Vertex Pharmaceuticals Inc | 23K | $10.4T | 3.3% | +29% |
| 10 | BSX | Boston Scientific Corp | 109K | $10.4T | 3.3% | +25% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ATLE SIGNAL
AC read
Atle Fund Management AB is a Other fund managing $26969.0 trillion in assets. The fund runs a portfolio of 38 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed